Mr. A. Waldock MD BMed Sci (Hons) BM BS FRCOphth Consultant Ophthalmic Surgeon Ophthalmology Training Programme Director, East of England Deanery.

Slides:

Advertisements

Similar presentations

V Glaucoma Implementing NICE guidance 2009 NICE clinical guideline 85.

Advertisements

Trabeculectomy + MMC Audit Mark Chiang, Clinical Research Fellow Mr. Peter Shah, Consultant Ophthalmic Surgeon Good Hope Hospital.

CATARACT SUEGRY AND DIABETES Indications of surgery: 1) Visual loss 2)Surveillance of retinopathy 3)Laser therapy.

Canadian Ophthalmological Society Evidence-based Clinical Practice Guidelines for the Management of Glaucoma in the Adult Eye.

© INTERNATIONAL GLAUCOMA ASSOCIATION (274681) 2009 The International GLAUCOMA Association Subhash Suthar D Pharm Development Manager.

Clinical Guidance and Monitoring for Change Cecilia Fenerty MD FRCOphth.

Providing the full range of Local Enhanced Services: The case of Manchester Karen O’Brien Associate Director Primary Care Commissioning.

EX-PRESS® Device in Clinical Practice New York September, 2011 Marlene R. Moster MD Professor of Ophthalmology Thomas Jefferson School of Medicine Wills.

ARAVIND EYE CARE SYSTEM Aravind Eye Hospital & Postgraduate Institute of Ophthalmology ARAVIND EYE CARE SYSTEM Aravind Eye Hospital & Postgraduate Institute.

Practical Ophthalmology for GPs: Glaucoma Mr Kuang Hu MA MB BChir PhD (Cantab) FRCOphth Consultant Ophthalmic Surgeon 9 October 2014.

SAMIR AL-MANSOURI, MD. e.g. - cataract - glaucoma - macular degeneration - diabetic retinopathy Chronic = slowly progressive visual loss Major causes:

0 Glaucoma can take your sight away. Keep Vision in Your Future.

Diabetes and vision. Summary Diabetes facts Changes to the eyes with diabetes Diabetic retinopathy –Background retinopathy –Proliferative retinopathy.

Andrew Crawford Ophthalmologist Diamond Valley Eye Clinic.

The Effect of the Restor Multifocal IOL on Frequency Doubling Perimetry Elizabeth Yeu, MD1, Elizabeth Woznak, BS2, Nicole Kesten, BS2, Steven VL Brown,

The Canadian Association of Optometrists

Glaucoma New Zealand - A Charitable Trust. Glaucoma New Zealand’s objectives are to: Eliminate blindness and visual disability from glaucoma in our community.

Evaluation of the FDT perimeter for detection of glaucoma. eastMED Doctors

Glaucoma Group of diseases characterized by increased intraocular pressure resulting in damage to the optic nerve and retinal nerve fibers.

Cataract in the 21st century Liana Al-Labadi, O.D. Lecture 6 Thanks To The Ohio State College of Optometry.

OPEN ANGLE GLAUCOMA Frank J. Weinstock, MD, FACS Professor of Ophthalmology- NEOUCOM Canton, Ohio USA.

Diabetes and Your Eyes.

Will my Glaucoma patient lose vision ?

RANDOMIZED CLINICAL TRIALS IN GLAUCOMA- WHAT DO THEY TELL US? Dr Jyoti Shetty B.W.Lions superspeciality eye hospital.

TARIQ ALASBALI WHICH PATIENTS ARE AT RISK FOR THE PROGRESSION?

South Hills Eye Associates

A TOUR OF THE WORLD OF GLAUCOMA SURGERY Dr. Jennifer Fan Gaskin Glaucoma Specialist.

>>0 >>1 >> 2 >> 3 >> 4 >> FULL PANRETINAL PHOTOCOAGULATION IMPROVES THE OUTCOME OF TRABECULECTOMY IN NEOVASCULAR GLAUCOMA Saleh alobeidan MD Essam osman.

Adult Medical-Surgical Nursing Neurology Module: Glaucoma.

January is Glaucoma Awareness Month The information and recommendations appearing on these pages are informational only and is not intended to be a basis.

Visual Impairment. Factors Affecting Visual Function and Their Treatment Visual Acuity - ability to see "detail" –Measured using testing distance/letter.

OCULAR FEATURES OF VERNAL KERATOCONJUNCTIVITIS IN CHILDREN REQUIRING TRABECULECTOMY WITH MITOMYCIN-C FOR STEROID-INDUCED GLAUCOMA CORDELIA CHAN FRCSEd.

Cataract Surgery After Trabeculectomy: The Effect on Trabeculectomy Function Husain R, Liang S, Foster PJ. Cataract surgery after trabeculectomy: the effect.

GLAUCOMA : A CHALLENGE IN A RURAL AREA IN BURKINA FASO SANOU Jérôme: Centre of Ophthalmology Zorgho - Burkina Faso RIGAL Karl : Light For The World - Austria.

Safety and efficacy of bromfenac ophthalmic solution 0.09% (Xibrom™) compared to prednisolone acetate 1% for treatment of ocular inflammation following.

WHY CARE ABOUT YOUR EYES? Brought to you by the Centre for Healthy Aging at Providence and CNIB An Eye Health Information Session.

Introduction  Selective Laser Trabeculoplasty (SLT) uses a Q-Switched frequency- doubled (532 nm), low energy Nd:YAG laser, which targets melanocytes.

Combined cataract surgery and endoscopic cyclophotocoagulation in patients with glaucoma without prior incisional glaucoma surgery Matthew P. Traynor,

PHACO-TRAB VERSUS PHACO ONLY IN EYES WITH ADVANCED OR END-STAGE GLAUCOMA WITH CONTROLLED INTRAOCULAR PRESSURE AND VISUALLY SIGNIFICANT CATARACT Liaska.

Dr. Abdullah Al-Amri Ophthalmology Consultant

Advanced Glaucoma and Cataract: Management Options Regenbogen Michael – Ichilov Amer Radgonde – Hadassah Ron Yonina – Beilinson Reyvitch Svetlana – Barsilai.

Glaucoma Care Project Team Members: Geoffrey T. Emerick, M.D. Erin Herlihy, B.S. Marilyn Hauser, M.B.A. Dianna Greening, R.N. Walter M. Jay, M.D Opportunity.

Effect of East Asian Race on Selective Laser Trabeculoplasty ASCRS 2011 Minerva Kim Johns Hopkins University Lawrence F. Jindra, MD Columbia University.

Glaucoma By: Courtney, Madison, Justin.  A group of eye conditions that can cause blindness.  However, with early detection and treatment, you can.

Conjunctivitis and Glaucoma. Conjunctivitis Conjunctiva- lines the eyelids and the sclera Conjunctivitis- inflammation of the conjunctiva caused by bacteria.

Evidence-Based Target Pressures Paul Palmberg, MD, PhD Bascom Palmer Eye Institute University of Miami School of Medicine How to Achieve Low Target Pressures.

Glaucoma Madhav Vempali Vempali Medical Ltd. Glaucoma The healthy eye Light rays enter the eye through the cornea, pupil and lens. These light rays are.

The Royal Victorian Eye and Ear Hospital 24-hour eye pressure and glaucoma Dr Simon Skalicky FRANZCO, MPhil, MMed (Ophthal Sci), MBBS (Hons 1) Visiting.

Glaucoma Lily T. Im, MD. What is glaucoma?   Glaucoma is a group of diseases that damage the eye’s optic nerve and can result in vision loss and blindness.

D.r Nishant Nawani, MS Dr. Surinder Singh Pandav, MD Dr. Amit Gupta, MD Dr. Sushmita Kaushik, MD Advanced Eye Centre PGIMER, Chandigarh The authors have.

CLASS™ by IOPtima Better & Safer Glaucoma Surgery Are you diagnosed with Glaucoma? Would you like to maintain your sight? Are you tired of applying medications?

(Relates to Chapter 22, “Nursing Management: Visual and Auditory Problems,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier.

Understanding Glauco ma. Femi Babalola Rachel eye center Garki, Abuja.

Simultaneous Cataract and ECP Glaucoma Surgery An opportunity to improve your vision while reducing or completely eliminating your dependence on Glaucoma.

A Santen company InnFocus mission

New trends in glaucoma U Faridi 11th November 2016.

A UK GLAUCOMA SERVICE IN 5 DAYS

InnFocus MicroShunt®.

Lasers in Glaucoma: Meta analysis

A presentation to: Meeting name Date

A presentation to: Meeting name Date

A presentation to: Meeting name Date

David B Henson Medical School University of Manchester

Clinical Cases in Glaucoma Treatment

Clinical study of open angle glaucoma surgery treatment trough deep slerectomy with T-Flux NV implant: three years follow-up Dr. Marco Rossi Dr Michele.

Glaucoma: Detect, Diagnose, And Monitor The Silent Thief of Vision

A presentation to: Meeting name Date

Ophthalmology Glaucoma

Presentation transcript:

Mr. A. Waldock MD BMed Sci (Hons) BM BS FRCOphth Consultant Ophthalmic Surgeon Ophthalmology Training Programme Director, East of England Deanery

Glaucoma Glaucoma thought to derive from the ancient Greek word… Glaukos… To glow or shine; blue-green; owl “Glaucosis” first documented by ancient Greeks in 400BC as a “blinding disease occurring most commonly in the elderly” “A group of diseases that have as a common end point a characteristic optic neuropathy which is determined by both structural change and functional deficit”

Classic glaucomatous optic neuropathy

Classic glaucomatous visual functional deficit

The Dilemma with Glaucoma Asymptomatic “Screening” by optometrists highlights “glaucoma” due to RAISED intra-ocular pressure (IOP) Prevalence of OAG in the UK estimated 1.2% In L&D catchment area, ~ 4000 patients Glaucoma <30% Eye Dept workload Diagnosing earlier and living longer

Management of Glaucoma Multidisciplinary approach Provide high quality diagnostic service Provide comprehensive treatment service offering:- A) Complete range of medications (eyedrops) B) Several laser treatments C) Modern glaucoma filtration surgery Multiple audits over last 10 years illustrate outcomes better than National Standard

Early Diagnosis and Accurate Monitoring of Glaucoma

Digital Imaging of Optic Nerve Head (ONH)

3-dimensional image illustrating ONH shape

Quantitative Analysis of Optic Nerve Head

Structural Change Analysis of Optic Nerve Head

Modern Laser Treatment for Mild Glaucoma

Selective Laser Trabeculoplasty (SLT)

SLT Audit / Outcomes Preliminary audit to confirm safety and efficacy Mean lowering of IOP = 4mmHg (20%) Range from 0% to 60% lowering of IOP from pre- treatment values 2:5 eyes had a >20% IOP lowering effect 1:7 non-responders 3% transient intra-ocular inflammation post-laser Summary: SLT is safe and effective

Definitive Modern Glaucoma Filtration Surgery for eyes not reaching target intra-ocular pressures

0.01mg/ml Mitomycin C trabeculectomy

MMC Trabeculectomy Audit / Outcomes 5 year follow up MMC Trabeculectomy outcomes IOP is lowered by 12mmHg (46%) at 5 years 30% no eyedrops at 5 years, rest on 1 medication Equates to a 91% success rate at 5 years 25% develop mild cataract, may require surgery MMC Trabeculectomy is safe & effective

Combined MMC Phaco-Trabeculectomy Audit / Outcomes 2 year follow up MMC Phaco-Trabeculectomy IOP is lowered by 10mmHg (45%) at 2 years 80% no eyedrops at 2 years, rest on 1 medication 47% demonstrate improvement in visual function Equates to a 85% success rate at 2 years MMC Phaco-Trabeculectomy is safe & effective

Cyclodiode Laser Treatment for Advanced Glaucoma and Painful Blind Eyes

Cyclodiode laser for advanced glaucoma

Cyclodiode Laser Audit / Outcomes Mean lowering of IOP = 8mmHg (28%) 3:4 eyes greater than 20% IOP lowering effect 50% required only single treatment session 3:5 painful eyes comfortable after one treatment 60% reduced eyedrops by 2 or more medications 8% complication rate (inflammation; loss of vision) Summary: Cyclodiode laser is safe and effective

The Glaucoma Time Plot Visual Functi on Age Patient diagnosed with glaucoma Normal Physiological Loss Significant visual impairment Birth 100 yrs Full Nil Aim of the glaucoma specialist: Not to manage blindness Preserve vision throughout life Do no harm!

Thank you for your attention